Oxidation of low density lipoproteins from patients with renal failure or a renal transplant. Peroxidation of low density lipoproteins (LDL) may be involved in the development of atherosclerosis which is prevalent in patients with chronic renal failure and renal transplant recipients. We determined the copper ion catalyzed oxidation in vitro, vitamin E content, and chemical and fatty acid composition of LDL isolated from 38 patients with renal disease and 15 healthy subjects. Also the acute effect of hemodialysis treatment on LDL oxidation variables was tested. The lag time in conjugated diene formation during oxidation was significantly (P = 0.011) shorter in LDL from renal transplant recipients (66 mm, N = 18) mainly due to significantly (P < 0.05) shorter times in women (47 mm, N = 7), compared with healthy subjects (83 mm, N = 15), patients on hemodialysis (91 mm, N 13) and patients treated by continuous ambulatory peritoneal dialysis (CAPD) (82 mm, N = 7). The maximum rate and the extent of LDL oxidation were significantly (P < 0.01) lower in all patients with renal disease compared with healthy subjects. The triglyceride content of LDL was significantly (P < 0.001) higher in women with kidney grafts (7.3%) compared with levels in the corresponding men (5.3%) and healthy women (5.0%), and was correlated significantly with the lag time in LDL oxidation in renal transplant recipients (Spearmans r = -0.502, P = 0.034). The percentage oleic acid in LDL was significantly higher (P = 0.002) and the percentage linoleic acid was significantly lower (P 0.046) in patients with renal disease, and may largely account for their lower rates and extent of LDL oxidation. Levels of the LDL oxidation variables and organic lipid peroxide content of LDL were not significantly different before and after hemodialysis and 24 hours later. These results suggest that LDL from women with renal transplants may be abnormally susceptible to oxidation possibly due to increased triglyceride content.
sclerosis in animals [11, 12] further support a role for lipid oxidation in the formation of arterial lesions. Oxidized LDL has several properties which are potentially atherogenic. For example, oxidatively modified LDL promotes accumulation of cholesteryl esters in cultured macrophages [8] reminiscent of foam cell formation which is a key step in the development of the atherosclerotic lesion. In addition oxidized LDL are cytotoxic [13] and are an attractant for macrophages [14] .
There is evidence that oxidative stress is increased in patients with chronic renal failure. Raised levels of lipid peroxidation products are found in plasma from uremic patients [15, 161 and during hemodialysis [17] , and activation of oxidative metabolism in polymorphonuclear leukocytes by the dialysis membrane has been observed [18] . These conditions could increase the susceptibility of LDL to oxidation. Recent studies have reported increased susceptibility to oxidation of LDL isolated from patients with chronic renal failure treated by hemodialysis or Continuous ambulatory peritoneal dialysis (CAPD) [19] . Reduced efficiency of the antioxidant vitamin E in LDL was also detected and may contribute to this increased susceptibility of hemodialyzed LDL to oxidation [20] . The acute effect of hemodialysis on the oxidation of isolated LDL was not tested. In renal transplant recipients, treatment with cyclosporine can increase the susceptibility of isolated LDL to oxidation if blood levels of the drug are high enough [20] . However, other factors including LDL lipid and fatty acid composition could influence oxidation of LDL from patients with chronic renal failure or kidney transplants. Circulating LDL is triglyceride-enriched in patients with renal failure [4] , and high LDL triglyceride content is associated with increased susceptibility of LDL to oxidation in vitro [10] . Fatty acid composition also influences the oxidation of isolated LDL with increased content of polyunsaturated fatty acids enhancing the susceptibility of LDL to oxidation and increased content of monounsaturates having the opposite effect [21, 22] . Furthermore, altered dietary intake of these fatty acids leads to predictable changes in the oxidation of isolated LDL [22] [23] [24] . Renal failure is frequently associated with changes in diet which could conceivably alter fatty acid composition and oxidation of LDL from these patients.
The aim of the present study was to compare the susceptibility to oxidation and the lipid, fatty acid, lipoperoxide and vitamin E content of LDL among renal transplant recipients, patients with chronic renal failure treated by hemodialysis or CAPD and healthy subjects. In addition, oxidation of LDL was measured immediately before, at the end, and 24 hours after hemodialysis to test the acute effect of this procedure on LDL oxidation. In this study we have used the terms "susceptibility or resistance to oxidation" to refer to the delay in onset of LDL oxidation (lag time) and "oxidizability" for the maximum rate of oxidation.
Methods

Subjects
Thirty-eight patients with chronic renal failure or kidney transplants (ages 19 to 78 years) were recruited from patients attending the Otago Nephrology Unit. Patients with nephrotic syndrome and patients receiving lipid-lowering therapy were excluded. Thirteen patients were on hemodialysis, seven were treated by CAPD and 18 were renal transplant recipients. The etiology of renal failure in the patients was as follows: glomerulonephritis (N = 22), reflux nephropathy (N = 5), hypertension (N = 4), autosomal dominant polycystic kidney disease (N = 2), diabetes mellitus (N = 2) and other causes (N = 3). Eight patients had evidence of ischemic heart disease (IHD) which was diagnosed on the basis of clinical symptoms and signs, along with ECG or echocardiographic changes or both. None of these patients had suffered an ischemic event. Eighteen patients were receiving cardiovascular medications. Angiotensin converting enzyme (ACE) inhibitors and/or dihydropyridine calcium channel antagonists were most frequently used to treat hypertension. Two patients were taking a beta-blocking drug. Most of the dialysis patients were taking calcium carbonate as a phosphate binder and 1-a-calcitriol supplementation. Two patients were receiving erythropoietin subcutaneously. Renal transplant recipients received azathioprine and prednisone ("double therapy," N = 5) or both these drugs and cyclosporine A ("triple therapy," N = 11) or cyclosporine A and prednisone (N = 2) to prevent rejection of the kidney graft. Patients treated by dialysis were either on home hemodialysis or CAPD. Hemodialysis patients were dialyzing three times weekly (12 to 18 hr/week) using cellulose acetate hollow fiber dialyzers and acetate dialysate. The usual length of a hemodialysis procedure was five hours. The Baxter Disconnect system was used by CAPD patients. Dietary protein intake was not restricted in any patient group and none of the patients was taking antioxidant supplements. Hemodialysis patients were advised to restrict intake of potassium-rich foods and fluid where necessary, but were not given any other dietary advice. Six patients including including three hemodialysis, one CAPD and two renal transplant recipients smoked; they were all men.
Fifteen healthy subjects (ages 31 to 52 years) were recruited from staff of the Dunedin Public Hospital and University of Otago. None was taking medication or antioxidant supplements and none smoked.
The study was approved by the Ethics Committee of the Otago Area Health Board and participants gave written and informed consent.
Lipoprotein separation
Venous blood was taken after an overnight fast and was collected in vacutainer tubes containing disodium EDTA (1.5 mg/mi). Blood was collected from hemodialysis patients immediately before a dialysis session, at the end of dialysis and at the 24 hour point. Plasma was separated by low-speed centrifugation at 4°C. Sequential ultracentrifugation (20 and 24 hr at 40,000 rpm in a Beckman 50.3 Ti rotor at 4°C) of plasma at densities 1.019 g/ml and 1.063 g/ml was used to separate LDL (d 1.019 to 1.063 g/ml) and VLDL+IDL (d 1.019 g/ml) fractions. LDL was dialyzed against phosphate buffered saline (PBS) pH 7.4 and then PS containing EDTA (5 jtmol/1iter) overnight at 4°C. The lipoprotein was stored in the dark at 4°C and was used within three days. Protein in LDL was measured by the Lowry method [251. High density iipoprotein cholesterol was measured in the supernatant after precipitation of apoB-containing lipoproteins with dextran sulphate/magnesium chloride [26] . Cholesterol and triglycerides were measured in plasma and lipoprotein fractions using enzymatic kits and calibrator supplied by Boehringer Mannheim Ltd (Germany). In addition free cholesterol and phosphoiipids were measured in LDL using enzymatic kits (Boehringer Mannheim Ltd). Plasma lipoprotein (a) was measured using a two-site radioimmunoassay kit (Pharmacia). Whole blood and plasma cyclosporine levels were measured in the laboratories of Dunedin Public Hospital by fluorescent polarization immunoassay using a commercial kit (Abbott TDX).
Oxidation of LDL
Copper ions were used to oxidize the isolated LDL, and the formation of conjugated dienes was measured to monitor oxidation. Conjugated diene formation was determined essentially as described by Sattler and coworkers [27] . To a quartz cuvette was added PBS (2 ml) which had been aerated for 15 minutes, an aliquot of LDL solution containing 50 jxg LDL protein and 5 jxmol/liter EDTA in PBS to bring the total volume to 2.2 ml. After the addition of 32 jd of 1 mmoi/liter copper sulfate the absorbance at 234 nm was monitored at 10 minute intervals. Quantities of conjugated dienes formed were calculated using the molar extinction coefficient (29500 liter/mol/cm) for conjugated dienes. The lag time was obtained from the intersection of lines drawn through absorbance values before oxidation started (lag phase) and during the following rapid oxidation (propagation phase) of LDL. The rate of conjugated diene formation during the propagation phase and also the maximum level of dienes attained were calculated.
Fatty acid composition
Heptadecanoic acid (20 jid ofa 1.15 mg/mi solution in toluene) internal standard was added to an aliquot (0.2 ml) of LDL solution (protein 0.3 to 0.9 g/liter). The mixture was extracted [28] . The combined extracts were evaporated to dryness under nitrogen, then redissolved in a small volume of chloroform/methanol (2:1) and transferred quantitatively to a Teflon screw-cap tube. The solvent was again evaporated under nitrogen and toluene (1 ml) and 14% boron trifluoride/methanol (2 ml) were added. The tube was securely capped then heated on a boiling water bath for 90 minutes. At the end of this transesterification step, the tube was cooled, water (1 ml) was added and the fatty acid methyl esters were extracted twice with hexane. The hexane extracts were brought to dryness under a stream of nitrogen, redissolved in a small volume of dichloromethane and transferred to a small conical minivial. The solvent was evaporated under nitrogen and the residue was redissolved in 50 ,td of dichloromethane. A 3 .tl sample of this solution was injected onto a Chromopack CP Sil88 capillary column (50 m X 0.22 mm) in a Varian 3700 gas chromatograph with a split-ratio set at 1:10. Helium (0.8 kg/cm2 column head pressure and flow rate 1.5 ml/min) was used as the carrier gas and the injector temperature was 260°C and the FID detector temperature was 280°C. Column temperature was programmed from 165°C to 210°C at 3°/mm.
Peak area was measured using a Spectra-Physics SP 4290 integrator. The peak quantification was based on peak area comparison with the internal standard and fatty acid composition was expressed in wt %. The concentrations of fatty acids in LDL (nmol/mg protein) were also calculated but are not reported.
Lipid peroxides
Organic lipid peroxide levels were measured in LDL prior to oxidation using the method of el-Sadaani and coworkers [29] modified to minimise binding of iodine to LDL {30J. LDL solutions were diluted to 0.30 g protein/liter with PBS containing 5 xmol/liter EDTA. Duplicate aliquots (100 pA) of the mixture were immediately taken, and 50 pA EDTA solution (3.7 mmol/ liter) and 10 .tl BHT solution (0.4 mmol/liter in methanol) were added. Next a volume (7 ILl) of aqueous iodine solution (1 mmol/liter) and 86 pA acetic acid solution (3%) was added to the aliquots of LDL and to standards containing hydrogen peroxide and a blank of distilled water. One milliliter of a commercial iodide cholesterol color reagent (Merck Ltd) was added to all tubes and after 30 minutes in the dark at room temperature, the absorbance of the reaction mixture was read at 365 nm against the blank.
Vitamin E content of LDL expressed in xmol!g LDL protein was measured by high pressure liquid chromatography according to the method of Bieri, Tolliver and Catiguiani [31] .
Statistical analysis
Comparison of values among groups of subjects were made using analysis of variances combined with Duncan's multiple range test. Student's t-test was used for comparing values between two groups of subjects. Pearson's product-moment correlation coefficients were used to test for relationships between variables. In one case, Spearman's rank correlation was used to reduce the effect of an outlying value on the correlation. Partial correlation analysis was used to test relationships between two variables while a third variable was held constant. Two-tailed tests of significance were used and a P value of less than 0.05 was considered to be statistically significant.
Results
Clinical characteristics and plasma lipids and lipoprotein concentrations of the subjects are shown in Table 1 . The CAPD patients were significantly older than the healthy subjects and other renal patients. Plasma creatinine concentration was lower in renal transplant recipients compared with dialyzed patients with renal failure due to a successfully functioning kidney graft.
Cholesterol concentration was significantly higher in plasma from CAPD patients and renal transplant recipients compared with healthy controls and hemodialyzed patients whose values were similar to those in the controls. Plasma VLDL+IDL cholesterol levels were significantly higher in patients treated by dialysis compared with levels in the healthy subjects and renal transplant recipients. The concentration of plasma HDL cholesterol in hemodialyzed patients was significantly lower than levels in healthy subjects and renal transplant recipients. Patients treated by CAPD had levels of HDL cholesterol which were similar to those in hemodialyzed patients and were significantly lower than levels in renal transplant recipients. Plasma Lp(a) concentration tended to be higher but not significantly (ANDVA P = 0.07, using log transformed data) in patients receiving dialysis.
The chemical composition and content of lipid peroxides and vitamin E in LDL from the subjects are shown in Table 2 . Patients treated by hemodialysis or CAPD had significantly lower content of free cholesterol and significantly higher content of triglycerides in LDL compared with renal transplant recipients and healthy subjects. The contents of protein and lipid peroxides were significantly higher in LDL from hemodialysis patients compared with other subjects. The vitamin E content in LDL from renal transplant recipients was significantly lower than levels in dialyzed patients with chronic renal failure. The ratio cholesterol/protein in LDL from hemodialysis patients (3.15 0.73 xmol/mg) was significantly (ANOVA P = 0.008) lower compared with values from other subjects (CAPD 3.57 0.36 jxmol/mg; renal transplant recipients 3.68 0.21 jxmol/mg; healthy subjects 3.60 0.26 xmol/mg).
The fatty acid composition of LDL from patients with renal disease and healthy subjects is shown in Table 3 . Oleic acid (18:1) content of LDL was significantly higher in all treatment categories of patients with renal disease compared with healthy subjects. Linoleic acid (18:2) content of LDL was significantly lower in patients treated by CAPD and tended to be lower in hemodialyzed patients compared with healthy subjects. There was substantial individual variation in lag time in LDL oxidation in renal transplant recipients (Fig. 1) , and those with shorter lag times outside the current range of values in healthy subjects were mainly women. Table 5 summarizes LDL oxidation and composition data in men and women treated by dialysis, with renal transplants and in the group of healthy subjects. Women with renal transplants had significantly shorter lag times in conjugated diene formation, lower LDL cholesteryl ester content and higher LDL triglyceride content compared with men with kidney grafts. Also the triglyceride content of LDL from these women was significantly (P < 0.001) higher than the corresponding value in healthy women. A significantly (P = 0.047) higher proportion of women with kidney grafts were treated with azathioprine and prednisone (22%), and a lower proportion were treated with cyclosporine in combination with prednisone and/or azathioprine (17%) compared with men (6% and 56%, respectively). Mean whole blood cyclosporine levels were 166 ng/ml (range 62 to 256 ng/ml) in women and 212 nglml (range 125 to 398 nglml) in men. The corresponding mean plasma levels were 70 ng/ml (women) and 104 nglml (men). The lag time was lower in women receiving triple therapy (27 11 mm, N = 3) compared with those receiving double therapy (62 24 mm, N = 4) at a marginal level of significance (P = 0.07). The content of triglycerides in LDL was not significantly different between these two groups of women. In men with renal transplants, the lag time was not significantly different between those receiving triple therapy (73 18 mm, N = 8) compared with those treated with double therapy (88 14 mm, N = 3). The proportion of women with renal transplants taking cardiovascular drugs (43%) was not significantly different from the corresponding proportion of men (36%). Also, age (men 44 14 years; women 40 12 years; mean SD) and LDL content of oleic acid (men 20.5 2.7%; women 20.6 2.6%) were not significantly different between men and women with renal transplants. In women treated by dialysis (hemodialysis or CAPD), the lag time was significantly longer, the maximum concentration of dienes produced was significantly less, LDL triglyceride content was higher at a marginal level of significance (P = 0.063) and LDL vitamin E content was significantly higher compared with values in men receiving dialysis. The content of oleic acid in LDL tended to be higher (women 24.4 3.2%; men 21.7 4.1%; mean SD) and the content of linoleic acid tended to be lower (women 30.1 7.1%; men 33.3 6.0%; mean SD) in women receiving dialysis, but these differences did not attain statistical significance. Table 6 shows the effect of hemodialysis on copper-catalyzed oxidation of isolated LDL from 12 out of the 13 patients treated by hemodialysis. None of the measured variables changed significantly during hemodialysis. Baseline lipid peroxide content of LDL also did not change significantly during hemodialysis (immediately before 45 8 nmol/mg; end 49 23 nmol/mg; 24 hr 46 6 nmol/mg; mean SD).
Since the patients with evidence of IHD were all dialysisdependent their characteristics were compared with those of the remaining dialysis-dependent patients who had no evidence of IHD, and these data are summarised in Table 7 . The patients with IHD were significantly older than those with no evidence of the condition.
Correlation analysis
The lag time (r = 0.357, N = 52, P = 0.009), rate (r = -0.670, N = 52, P < 0.001) and maximum concentration (r = -0.615, N = 52, P < 0.001) of conjugated dienes formed were correlated significantly with the oleic acid content of LDL in all subjects combined (Fig. 2) . The rate (r = 0.627, N = 52, P < 0.001) and maximum concentration (r = 0.561, N = 52, P < 0.001) of dienes formed were also correlated significantly with the linoleic acid content of LDL (Fig. 3) . The lag time was correlated significantly with the triglyceride content of LDL in renal transplant recipients (Fig. 4) but not in the other groups of subjects (hemodialysis: r = -0.164; CAPD: r = 0.276; healthy subjects: r = -0.190). In those who were receiving "triple therapy," the lag time was not corre- Significance of difference between mean values for men and women (Student's t-test): a P < 0.05; b P < 0.001 a "Before" is immediately prior to dialysis and "end" is immediately Discussion Oxidation of LDL is believed to be an important step in the development of atherosclerosis [8] . Since atherosclerotic disease is prevalent in patients with chronic renal failure or renal transplants, we sought evidence that LDL from these patients is more susceptible to oxidation in vitro. Our data show that lag times in conjugated diene formation are abnormally short when LDL from women with renal transplants are oxidized in vitro, suggesting that the susceptibility of the lipoprotein to oxidation may be increased in these women.
The inverse correlation between lag time and LDL triglyceride content in the present renal transplant recipients suggests that the short lag time in LDL oxidation in women with kidney grafts may be due in part to the abnormally high content of triglycerides in the lipoprotein. Triglyceride-enrichment of LDL has also been associated with increased susceptibility to copper ion oxidation in b Significance calculated on log transformed data male survivors of myocardial infarction in a previous study [10] .
The mechanism underlying this association is not clear. It is possible that triglyceride-enrichment may alter the physicochemical properties of LDL and thereby increase the susceptibility of the lipoprotein to oxidation. In the present study, LDL from men and women receiving dialysis treatment were also triglycerideenriched but lag times in LDL oxidation were not reduced. This finding may be due to increased antioxidant protection as a result of the higher content of vitamin E in LDL from these patients compared with the renal transplant recipients. Vitamin E is the most abundant antioxidant in LDL and raising the levels of this antioxidant increases the lag time in LDL oxidation [32] . Cyclosporine at blood levels greater than 100 ng/ml is reported as accelerating the oxidation of isolated LDL [20] . In the present study, LDL from women receiving triple therapy tended to be particularly susceptible to oxidation, suggesting that cyclosporine treatment may have contributed to the short lag time in LDL oxidation in women with kidney grafts. However, plasma cyclosporine levels were unrelated to LDL oxidation in renal transplant recipients and cyclosporine treatment did not appear to have greatly influenced the oxidation of LDL from men with kidney grafts. They had lag times in LDL oxidation that were not clearly 30 18:2 (wt%) different from normal in spite of the fact that their blood cyclosporine levels were higher than levels (100 ng/ml) reported as stimulating LDL oxidation in vitro [20] . This apparent ineffectiveness of cyclosporine treatment on LDL oxidation in men is unexplained. Although captopril (an ACE inhibitor) and /3-blocking drugs are reported as reducing the susceptibility of isolated LDL to oxidation [33, 34] , there was no evidence in our data that treatment with cardiovascular drugs had any appreciable influence on LDL oxidation in renal transplant recipients or in the total group of renal patients.
In this study and in a previous report [21] , the lag time in conjugated diene formation was linked with LDL oleate content, but this relationship did not appear to explain the abnormally short lag times in oxidation of LDL from the present women with renal transplants. Thus the fatty acid composition of LDL was similar in men and women with kidney grafts while lag times were markedly longer in the men. Once antioxidant protection was depleted, the rate and extent of conjugated diene formation from LDL isolated from renal patients, and more particularly those treated by dialysis, were lower than values in healthy subjects. The close correlations between these oxidation variables and LDL content of oleic acid (inverse) and linoleic acid (positive) suggest that lower LDL linoleate and higher LDL oleate content contributed to the lower rate and extent of conjugated diene formation in LDL from dialysis patients. Similar relationships have been reported previously in mildly hypercholesterolemic patients [22] and a combined group of healthy subjects and vitamin E-deficient individuals [21] . Furthermore, changes in LDL content of oleate and linoleate by supplementing the diet with these fatty acids produces the predicted changes in rate and extent of LDL oxidation [22] [23] [24] . Usually a faster maximum rate accompanies a shorter lag time in LDL oxidation, but in the present renal transplant recipients the lag time was shorter and the rate of diene formation was slower than normal. This apparent discrepancy may be due to comparatively high LDL oleate content which is associated with slower rates of diene formation.
In contrast to a recent report of increased susceptibility to oxidation of LDL isolated from dialysis patients [19] , LDL from the corresponding patients in the present study was not abnormally prone to oxidation. Whether or not these differing findings are related to the shorter lag times in conjugated diene formation in LDL from the dialysis patients and healthy subjects we studied compared with those reported previously [19] is uncertain. Vitamin E content of LDL was lower and may explain the shorter lag times in our data. Also, the patients reported on by Maggi et al [19] were from Italy where the diet is usually rich in olive oil, and could therefore lead to LDL that is enriched in oleic acid and particularly resistant to oxidation [22] [23] [24] . It seems unlikely that oxidation of LDL during its separation from plasma is mainly responsible for the shorter lag times we observed because EDTA was present throughout the isolation procedure. Lipid peroxide levels were abnormally high in LDL from the current hemodialysis patients, but this finding has been documented previously [17] . There is evidence that enrichment with lipid peroxides increases the susceptibility of LDL to oxidation by copper ions [35, 36] . However, in spite of increased lipid peroxide content hemodialyzed LDL was not abnormally susceptible to oxidation in the present study. It is possible that the higher vitamin E content and lower cholesterol/protein ratio may have counteracted any prooxidant effects of raised lipid peroxide levels in hemodialyzed LDL. In support of this hypothesis, Frei and Gaziano [36] have reported that a low cholesterol/protein ratio is associated with increased resistance of LDL to oxidation by copper ions. In the present study, the comparatively normal resistance of hemodialyzed LDL to oxidation seems to be consistent with the finding that acute hemodialysis did not alter the susceptibility of LDL to oxidation, and the duration of hemodialysis treatment and the lag time in LDL oxidation were unrelated. These variables were also unrelated in the study reported by Maggi et al [19] .
Acute smoking is reported as raising LDL lipid peroxide content and increasing the susceptibility of the isolated lipoprotein to oxidation [37] . Accordingly, LDL from current hemodialysis patients who smoked showed increased susceptibility to oxidation, but this did not appear to be mediated by lipid peroxide content of the lipoprotein which was similar in smokers and nonsmokers. Overall, there were few smokers and smoking status did not appreciably influence major findings on LDL oxidation in this study.
We isolated plasma LDL between densities 1.019 g/ml and 1.063 g/ml and the lipoprotein fraction may therefore contain varying quantities of Lp(a) that has a longer lag time than LDL during copper ion oxidation [27] . It is unlikely that Lp(a) content of the LDL fraction greatly influenced the lag times in diene formation that we observed in renal patients, because lag times were similar in CAPD patients and healthy controls despite higher levels of plasma Lp(a) in the patients.
In the present study, the maximum rates of LDL oxidation suggest that LDL from all patients with renal disease, and particularly those receiving dialysis, may be less readily oxidized than normal. In contrast, lag times in LDL oxidation suggest that the susceptibility of the lipoprotein to oxidation is comparatively normal in most patients with renal disease, excepting women with renal transplants whose LDL is more prone to oxidation. This inconsistency raises the question which index of LDL oxidation should be given greater weight in assessing the potential of LDL for oxidation in vivo. De Graaf and coworkers [38] have suggested that more value should be given to the duration of the lag time in conjugated diene formation because at the end of this period there are alterations in LDL that could theoretically influence its biological activity, Indeed, increased levels of minimally oxidatively modified LDL would be expected during or not long after the end of the lag time, and these particles have potentially atherogenic properties [39] . On the other hand, if an LDL particle becomes trapped within the intimal matrix and subjected to sustained oxidative stress, the rate and extent of LDL oxidation may also be important in determining the subsequent likelihood and degree of any atherosclerotic changes. Recent evidence suggests that oxidation of LDL in vitro may not necessarily parallel in vivo oxidation of the lipoprotein measured as circulating levels of autoantibodies to oxidized LDL [40] . Increased levels of these antibodies have been detected in patients receiving dialysis [41] , which seems to be at variance with our finding of normal susceptibility to in vitro oxidation of LDL isolated from this category of patients. Further studies comparing these measures of LDL oxidation are required. Regnstrom and coworkers have reported that the lag time in LDL oxidation is correlated inversely with the severity of coronary atherosclerosis in men with a first myocardial infarction [10] . However, the presence of subjects with evidence of IHD did not appear to influence our findings, and values for LDL oxidation variables were similar in dialysis dependent patients with chronic renal failure with or without evidence of IHD, and none of the women with renal transplants had clinically important cardiovascular disease. A recent study has reported similar levels of circulating autoantibodies to oxidized LDL, suggesting that rates of LDL oxidation in vivo may also be similar in dialysis patients with or without IHD [41] . It is possible that subclinical vascular disease was present in patients without evidence of IHD, and that there were differences in lifestyle that may have obscured any difference in LDL oxidation associated with IHD. On the other hand, it is also possible that LDL oxidation is not the predominant risk factor for IHD in dialysis patients. The classical risk factors including older age and higher plasma LDL cholesterol levels tended to distinguish patients with evidence of IHD in our data.
There are limitations to the present findings. The main study was cross sectional, and levels of variables prior to treatment for kidney failure are unknown. The numbers of subjects in each category of renal patients were comparatively small, increasing the risk of a non-representative sample. On the other hand, clinical findings and plasma lipid and lipoprotein levels in patients in the treatment groups were essentially in agreement with reported data [4] [5] [6] . The trend toward high levels of HDL cholesterol in the renal transplant recipients we studied has been noted in some [42] , but not all studies [43, 44] , and is possibly due to immunosuppressive therapy and improved renal function [421.
In conclusion, this study has provided evidence that LDL from women with renal transplants is abnormally susceptible to oxidation in vitro, and we speculate that this may possibly increase their risk of future atherosclerotic disease. Measurement of autoantibodies against oxidized LDL is required to confirm that oxidation of LDL in vivo may also be increased in these women.
